Alkermes’ schizophrenia drug shows lower weight gain than comparator

Alkermes’ schizophrenia drug shows lower weight gain than comparator

The company plans to file a New Drug Application next year. An analyst wrote that it’s unclear if the drug will require review by an advisory committee.

Source: https://ift.tt/2SfdxDk